Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets
Cash	$ 271,773	$ 289,925
Cash collateral posted to counterparties	79,471	263,799
Agency Securities, available for sale, at fair value (including pledged securities of $6,298,811 at December 31, 2016 and $12,109,868 at December 31, 2015)	6,511,164	12,461,556
Derivatives, at fair value	9,837	999
Principal payments receivable	0	37
Accrued interest receivable	18,452	34,500
Prepaid and other	1,667	4,461
Total Assets	7,978,161	13,055,277
Liabilities:
Repurchase agreements	6,818,453	11,570,481
Cash collateral posted by counterparties	3,774	0
Derivatives, at fair value	49,655	233,301
Accrued interest payable- repurchase agreements	6,934	7,724
Accounts payable and other accrued expenses	7,280	18,605
Total Liabilities	6,886,096	11,830,111
Commitments and contingencies
Preferred stock, $0.001 par value, 50,000 shares authorized;
Common stock, $0.001 par value, 125,000 shares authorized, 36,723 and 36,682 shares issued and outstanding at December 31, 2016 and December 31, 2015	37	37
Additional paid-in capital	2,560,242	2,559,361
Accumulated deficit	(1,439,088)	(1,266,938)
Accumulated other comprehensive loss	(29,134)	(67,302)
Total Stockholders’ Equity	1,092,065	1,225,166
Total Liabilities and Stockholders’ Equity	7,978,161	13,055,277
Series A Preferred Stock
Preferred stock, $0.001 par value, 50,000 shares authorized;
Preferred stock	2	2
Series B Preferred Stock
Preferred stock, $0.001 par value, 50,000 shares authorized;
Preferred stock	6	6
Non-Agency Securities
Assets
Trading securities, at fair value	1,052,170	0
Interest-Only Securities
Assets
Trading securities, at fair value	$ 33,627	$ 0